Clinical trials in Reghin

In Reghin, clinical trial activity includes research in immune system diseases with a strong focus on moderate to severe plaque psoriasis. These studies are designed to evaluate the long-term safety and treatment performance of new and existing therapies, helping clarify how well they support disease control in everyday care.

• Moderate to severe plaque psoriasis
• Long-term treatment safety
• Comparison of therapeutic effectiveness

This area reflects ongoing efforts to improve care options for chronic inflammatory skin disease while monitoring overall treatment safety.

Another active research area in Reghin is nutritional and metabolic diseases, especially studies involving type 2 diabetes and overweight or obesity. The trials are focused on testing whether new therapies can better lower blood sugar, reduce body weight, and improve metabolic control.

• Type 2 diabetes
• Overweight or obesity
• Blood sugar control
• Weight management

These studies aim to support better treatment strategies for people living with common, long-term metabolic conditions.

Clinical trials in this category are examining treatments for type 2 diabetes in people who need improved glycaemic control. The research is centered on whether newer options can offer stronger effects on HbA1c and overall cardiometabolic health compared with established therapies.

• Type 2 diabetes
• HbA1c improvement
• Metabolic treatment effectiveness

This work supports the search for more effective ways to manage diabetes in routine clinical practice.